Here, we investigated the molecular basis of NRF2/NOTCH crosstalk deregulation by KEAP1 in SCLC and evaluated its impact on impairing responses to conventional chemotherapies and NOTCH inhibitors. Here, KEAP1 is linked to small cell lung carcinoma.